R&G PharmaStudies

R&G PharmaStudies

诺思格(北京)医药科技开发有限公司 是国内领先、规模最大的临床合同研究组织(CRO)之一。运营团队由国内外众多专家组成,致力于为客户提供符合国际标准的高质量、高效率临床研究服务。 诺思格拥有全方位的临床试验CRO服务能力、丰富的临床试验经验以及严格的标准操作流程系统。公司现有国际化的管理团队及超过700人的专业化运营团队,通过不断提升技术水平和服务质量,在国内外市场建立了良好的口碑。自成立以来,诺思格已与全国400多家医疗机构开展合作。诺思格重视公司的国际化发展,已为国内外200多个客户提供高质量、高效率、符合国际标准的CRO服务。 诺思格将一直坚持诚信高效的服务理念,用心做事,努力成为客户信赖、社会尊重的国际化一流企业。

Visit Website

Locations

  • APAC

Therapeutic Areas

  • Cardiovascular
  • Diabetes
  • Endocrinology
  • Oncology

Accreditations

Partners are trained on the functionality of the Coder application, process optimization, and scope of Coder services. This Accreditation teaches Partners to integrate the medical coding solution with EDC studies and administer Coder segments. Coder Accreditation is dependent on the successful completion of the Rave EDC accreditation.
Partners are trained on the functionality of the electronic data capture (EDC) and clinical data management (CDM) system, process optimization exercises and scope of Medidata Rave services. This Accreditation teaches the staff to perform end user training, user and site administration, study build, reporting, outputs and amendment manager.
Partners are trained on the functionality of the RTSM Application, process optimization, best practices using RTSM, and scope of RTSM services. This Accreditation teaches Partners to conduct randomization and clinical trial supply management services (RTSM). RTSM Accreditation is dependent on the successful completion of the Rave EDC Accreditation.